emr Archives - The Dark Intelligence Group

TAG:

emr

Monitoring Patients on Opioids Is Opportunity for Clinical Labs

By Joseph Burns | From the Volume XXVI No. 13 – September 23, 2019 Issue

CEO SUMMARY: When developing a program to identify and treat patients who misused opioids or needed chronic opioid therapy, Community Health Network (CHN) of Indianapolis recognized that clinical lab toxicology tests were one of the few sources of objective data about patient compliance….

Monitoring Patients on Opioids with Toxicology Screens Is Opportunity for Clinical Labs

By Mary Van Doren | From the Volume XXVI No. 13 – September 23, 2019 Issue

This is an excerpt of a 2,883-word article in the Sept. 23, 2019 issue of THE DARK REPORT (TDR). The full article is available to members of The Dark Intelligence Group. CEO SUMMARY: In this first industry briefing on such a program, THE DARK REPORT exp…

Sonic Uses Lab Data, Patient-Contact Tools, to Improve Outcomes

By Joseph Burns | From the Volume XXV No. 16 – November 13, 2018 Issue

CEO SUMMARY: In its work for a federally qualified health center, Sonic Healthcare USA helped physicians use a data-driven approach to population health management that incorporated integrated financial and clinical analytics. Also, Sonic developed technologies that give ordering physicia…

LAB BRIEFS

By Robert Michel | From the Volume XXV No. 4 – March 5, 2018 Issue

DUBAI TO TEST DNA OF ITS 3 MILLION CITIZENS RECENTLY, GOVERNMENT OFFICIALS in Dubai announced a plan to conduct genetic testing on all three million residents. Experts say this is an unprecedented decision by any national govern…

Positive Patient ID System Catches Patients Cheating on Toxicology Tests

By Pamela Scherer McLeod | From the Volume XXIV No. 13 – September 18, 2017 Issue

CEO SUMMARY: The urine drug testing industry is challenged every day to detect the large number of patients trying to cheat on their drug tests. GenoTox Laboratories of Austin, Texas, developed a DNA-authentication method for urine samples that allows the lab to detect when patients have …

UnitedHealth to Start Gene Test Pre-Approval

By Joseph Burns | From the Volume XXIV No. 12 – August 28, 2017 Issue

CEO SUMMARY: With programs now at the nation’s two largest insurers, is it possible to argue that prior-authorization is going mainstream? Some observers say, yes, as THE DARK REPORT predicted. What is certain is that starting Nov. 1, UnitedHealthcare is requiring prior authorization fo…

Labs: Watch for Whistleblowers! You Can’t Predict Who’s Filing

By Robert Michel | From the Volume XXIV No. 9 – June 26, 2017 Issue

NEWS STORIES ABOUT TWO DIFFERENT FEDERAL WHISTLEBLOWER CASES against lab companies provide a reminder that managers of every clinical laboratory and pathology group must be vigilant about compliance, because potential whistleblowers can emerge from the unlikeliest of places. The first example involv…

Health System Lab Is Genotyping To Identify Best Drugs for Patients

By Joseph Burns | From the Volume XXIV No. 2 – January 30, 2017 Issue

CEO SUMMARY: One essential element of precision medicine will be the regular use of pharmacogenomic testing to provide additional guidance to physicians when selecting the most appropriate therapeutics and optimal dose for each individual patient. Despite the reluctance of private payers …

In Texas, BeaconLBS Start Will Be Delayed

By Joseph Burns | From the Volume XXIV No. 2 – January 30, 2017 Issue

CEO SUMMARY: UnitedHealthcare will not implement the claims impact part of its laboratory benefit management program in Texas on March 1, 2017, as it had previously announced. Opposition to the program and the requirement that physicians use the BeaconLBS system when ordering about 79 lab…

Pharmacogenomic testing a success at South Dakota health system

By Mary Van Doren | From the Volume XXIV No. 2 – January 30, 2017 Issue

This is an excerpt from a 2,700-word article in the January 30 issue of THE DARK REPORT. The complete article is available for a limited time to all readers, and available at all times to paid members of the Dark Intelligence Group. CEO SUMMARY: One es…

Volume XXVIII, No. 4 – March 22, 2021

THERE’S POSITIVE NEWS FOR LABS on several fronts. For one, the daily number of routine test specimens is near pre-pandemic levels and certain sectors of lab testing—particularly genetic tests and some high-cost assays—are showing substantial growth this year, compared to 2019. Also, the Stark Law and AKS have been revised to make it easier for labs to comply.

See the full table of contents

How Much Laboratory Business Intelligence Have You Missed?

Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!

Need A Group Membership? Company Discounts are Available!

Sign up for TDR Insider

Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.

Topics

Visit The Dark Library

TAG:

emr

CURRENT ISSUE

How Much Laboratory Business Intelligence Have You Missed?

Sign up for TDR Insider

Topics